Clinical Trial Update: A Study of RO7239958 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection [Phase 1]

View source ↗

Summary

Phase 1 study of RO7239958 in healthy volunteers and Hepatitis B patients was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• RO7239958

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis B Virus Infection | Phase 1 | Status: TERMINATED | Results posted: 2021-04-09